Denali Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-5.40-6.97-15.6416.37
Price/Sales ratio
16.946.854.052.37
Earnings per Share (EPS)
$-2.73$-2.12$-0.94$0.90

Historical Multiples (2015 – 2023)

2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-3.84-1.59-2.65-52.80-8.42128.31-18.65-10.70-20.29-9.7159.94
Price/Sales ratio
N/AN/AN/A14.8162.4227.19111.3832.188.9129.2044.81
Price/Book Value ratio
-4.120.540.503.494.217.935.633.342.853.036.07
Price/Cash Flow ratio
-4.28-1.90-3.0538.18-10.9821.93-25.63-14.26-8.23-12.945.47
Price/Free Cash Flow ratio
-3.56-1.75-2.9440.95-9.8222.09-24.64-13.29-7.94-12.066.13
Price/Earnings Growth ratio
N/A-0.010.040.56-0.01-0.970.03-1.210.340.970.27
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/A94.25%-624.87%36.65%88.47%93.51%94.93%N/A-312.43%
Operating Profit Margin
N/AN/AN/A-35.90%-799.10%18.68%-607.77%-314.15%-59.51%-314.15%-556.62%
Pretax Profit Margin
N/AN/AN/A-28.05%-742.05%21.43%-598.33%-300.53%-43.92%-300.53%-521.29%
Net Profit Margin
N/AN/AN/A-28.05%-740.73%21.19%-597.15%-300.55%-43.93%-300.55%-520.64%
Effective Tax Rate
N/AN/A3.49%-27.95%0.17%1.14%0.19%-0.00%-0.02%-0.00%0.66%
Return on Assets
-45.76%-31.96%-18.11%-5.47%-35.72%4.43%-20.69%-22.32%-12.58%-22.32%-20.59%
Return On Equity
107.38%-34.04%-18.93%-6.62%-50.04%6.18%-30.19%-31.27%-14.08%-35.66%-42.85%
Return on Capital Employed
-50.23%-33.37%-19.07%-7.37%-41.97%4.09%-28.82%-31.08%-18.28%-31.08%-24.67%
Liquidity Ratios
Current Ratio
N/AN/A28.9114.669.4820.86N/AN/AN/A3.7715.17
Quick Ratio
9.6019.9828.9514.929.4820.862.373.7813.643.6715.17
Cash ratio
8.834.3715.412.351.757.070.770.591.620.594.41
Days of Sales Outstanding
N/AN/AN/A24.15N/AN/A9.1931.233.77N/AN/A
Days of Inventory outstanding
N/AN/A-54.95-420.67N/AN/AN/A-259.52N/AN/AN/A
Operating Cycle
N/AN/AN/A-396.52N/AN/A9.19-228.293.77N/AN/A
Days of Payables Outstanding
5.16K487.74321.6593.084.881.83310.98144.81206.94N/A3.36
Cash Conversion Cycle
N/AN/AN/A-489.60-4.88-1.83-301.79-373.10-203.16N/A-247.24
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.28N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.40N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.04N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.05N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-23.06N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-4.05N/A
Company Equity Multiplier
-2.341.061.041.211.401.391.451.401.111.401.39
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/A0.38-5.681.23-4.34-2.25-1.08-2.25-3.96
Free Cash Flow / Operating Cash Flow Ratio
1.201.081.030.931.110.991.041.071.031.071.09
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-4.05N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-33.44N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A